Consumer Healthcare | ESM Magazine

Pfizer To Cut Stake In Sensodyne Toothpaste-Maker Haleon To 24%

Consumer healthcare firm Haleon has said that U.S. drugmaker Pfizer, its top shareholder, will sell down its stake in the company to about 24%.

Haleon Reports Sluggish First-Quarter Growth

Despite price increases, Haleon's roster of products has largely kept cheaper private-label competition at bay, although the cost-of-living squeeze and com...

Unilever Investor Lindsell Train Says Changes Mark Fresh Approach

Unilever top-10 investor Lindsell Train welcomed its recent management changes and said it had already discussed the consumer goods company's next ste...

Haleon Misses Revenue Estimates As North America Demand Drags

Haleon missed market estimates for third-quarter revenue, as the world's largest consumer healthcare firm grappled with weak demand for its painkillers, di...

France's Sanofi Considers Listing Consumer Unit Late Next Year

Sanofi has mapped out a separate listing of its consumer healthcare business from the fourth quarter of next year, the French drugmaker said, adding it pla...

GSK Cuts Stake In Haleon To 7.4%, Raises £885.6m

British drugmaker GSK said it raised £885.6 million (€1 billion) from a discounted stake sale in Haleon, cutting its shareholding to 7.4%.

PZ Cussons Looks To Delist Nigeria Unit With Offer To Minority Shareholders

Soap maker PZ Cussons said it has offered to buy out minority shareholders of PZ Cussons Nigeria (PZCN) and aims to de-list the busines...

Haleon Raises Annual Organic Revenue Growth Forecast On Steady Demand

Haleon has raised its forecast for annual organic revenue growth, as the consumer healthcare company is confident that demand for its oral and respiratory...